These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35038132)

  • 1. Cardiovascular Morbidity in Individuals with Impaired FEV1.
    Mathew J; Nickel NP
    Curr Cardiol Rep; 2022 Mar; 24(3):163-182. PubMed ID: 35038132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease?
    Stone IS; Barnes NC; Petersen SE
    Heart; 2012 Jul; 98(14):1055-62. PubMed ID: 22739636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular comorbidity in COPD: systematic literature review.
    Müllerova H; Agusti A; Erqou S; Mapel DW
    Chest; 2013 Oct; 144(4):1163-1178. PubMed ID: 23722528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnoea Syndrome and Overlap Syndrome.
    Voulgaris A; Archontogeorgis K; Steiropoulos P; Papanas N
    Curr Vasc Pharmacol; 2021; 19(3):285-300. PubMed ID: 32188387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular and chronic obstructive pulmonary diseases: pathophysiological processes and treatment tactics].
    Ambatiello LG; Chazova IE
    Ter Arkh; 2020 Apr; 92(3):78-83. PubMed ID: 32598797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into Chronic Obstructive Pulmonary Disease as Critical Risk Factor for Cardiovascular Disease.
    Almagro P; Boixeda R; Diez-Manglano J; Gómez-Antúnez M; López-García F; Recio J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():755-764. PubMed ID: 32341642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease and risk in COPD: a state of the art review.
    Polman R; Hurst JR; Uysal OF; Mandal S; Linz D; Simons S
    Expert Rev Cardiovasc Ther; 2024; 22(4-5):177-191. PubMed ID: 38529639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease.
    Sin DD; Man SF
    Can J Physiol Pharmacol; 2005 Jan; 83(1):8-13. PubMed ID: 15759045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retrospective study on the prevalence of cardiovascular comorbidities in 4960 inpatients with chronic obstructive pulmonary disease in Beijing].
    Wei ZM; Cai JF; Cui H; Liu AM; Li Y; Gao F; Fan L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Mar; 32(3):297-301. PubMed ID: 21457669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality.
    Sin DD; Man SF
    Proc Am Thorac Soc; 2005; 2(1):8-11. PubMed ID: 16113462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease.
    Onishi K
    J Cardiol; 2017 Aug; 70(2):128-134. PubMed ID: 28325523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease and cardiovascular disease.
    Bhatt SP; Dransfield MT
    Transl Res; 2013 Oct; 162(4):237-51. PubMed ID: 23727296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic obstructive pulmonary disease and cardiovascular diseases].
    Passowicz-Muszyńska E; Gostkowska-Malec A; Jankowska R; Piesiak P
    Pneumonol Alergol Pol; 2010; 78(1):28-32. PubMed ID: 20162516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease: A Nested Case-Control Study.
    Wang MT; Liou JT; Lin CW; Tsai CL; Wang YH; Hsu YJ; Lai JH
    JAMA Intern Med; 2018 Feb; 178(2):229-238. PubMed ID: 29297057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHA2DS2-VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary disease.
    Ooi H; Chen LH; Ni YL; Shen HT; Lee YH; Chu YC; Fang KC; Chen IH; Hsu SL; Chen HC; Huang CH; Fan KS; Lai CL; Hang LW
    Clin Respir J; 2018 Mar; 12(3):1038-1045. PubMed ID: 28268258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice.
    Maeda T; Dransfield MT
    Curr Opin Pulm Med; 2024 Mar; 30(2):141-149. PubMed ID: 38085609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexisting chronic obstructive pulmonary disease and cardiovascular disease in clinical practice: a diagnostic and therapeutic challenge.
    Leong P; Macdonald MI; Ko BS; Bardin PG
    Med J Aust; 2019 May; 210(9):417-423. PubMed ID: 30907000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chinese expert consensus on the management of cardiovascular comorbidities in patients with chronic obstructive pulmonary disease].
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Dec; 45(12):1180-1191. PubMed ID: 36480848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study.
    Sawalha S; Hedman L; Backman H; Stenfors N; Rönmark E; Lundbäck B; Lindberg A
    Ther Adv Respir Dis; 2019; 13():1753466619860058. PubMed ID: 31291820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.